India's Syngene International slips after quarterly profit drop

Syngene International

23/01/2026 05:06

** Shares of Syngene International SYNN.NS fall as much as 5.6% to a near three-year low of 559.10 rupees, last down 2.3%
** The contract research firm's Q3 net profit dips ~89% year-on-year to 150 million rupees ($1.6 million); revenue slips 2.8% y/y

** Macquarie says revenue shortfall was primarily driven by lower sales of a key biologics product, reflecting normalisation of quarterly revenue

** Brokerage expects SYNN's earnings growth to continue in FY26, with operational efficiencies and capacity addition at its plants as well as new client additions supporting earnings growth through the year
** Avg rating of 8 analysts is "buy" and median PT is 725 rupees - data compiled by LSEG

** SYNN fell 24.1% in 2025

($1 = 91.6100 Indian rupees)

(Reporting by Brijesh Patel in Bengaluru)

((Brijesh.Patel1@thomsonreuters.com; Ph no. +91 9590227221;))